Efficacies of oxycodone and morphine sulfate sustained-release tablets in treating moderate and severe cancer pain

Chinese Journal of New Drugs

Volumn 18, Issue 4, 2009, Pages 337-339

  Song, Ji Fu ^a   Zhao, Yong Li ^a   Zhou, Hong Mei ^a   Wang, Hong Jian ^a   Li, Kai Yan ^a  

^a Jiaozhou Central Hospital of Qingdao   (China)

Author keywords

Adverse reactions; Mitigation; Morphine sulfate sustained release tablets; Oxycondon; Pain

Indexed keywords

MORPHINE SULFATE; OXYCODONE;

ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET; THERAPY EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 77953838733     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Report a WHO Expert Committee. Cancer Pain Relief and Palliative Care[ S]. Geneva. 1990.
2. WHO. The World Health Report 1998 , List in the21t Centur a Version for All [ R ]. Geneva. 1998.
3. PEARL ML, MCCAULEY DL, THOMPSON J, et al. A randomized controlled trial of early oral analgesia in gynecologic oncology patients undergoing intra-ab-dominal surgery[ J]. Obstet Gynecol, 2002, 99(5 pt1) :704-708.